Emma Guttman‐Yassky
- Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
2020/10/01 by Andreas Wollenberg, A. Wollenberg, A. Blauvelt +39 · 35 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Allergic Rhinitis and Sensitization #Psoriasis: Treatment and Pathogenesis
- Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
2020/01/30 by E.L. Simpson, Eric L. Simpson, J.‐P. Lacour +43 · 29 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Allergic Rhinitis and Sensitization
- The epithelial barrier theory and its associated diseases
2024/10/07 by Na Sun, İsmail Öğülür, Yasutaka Mitamura +43 · 1 voice · 10 citations
Biochemistry, Genetics and Molecular Biology · Health Professions · Neuroscience · #Gut microbiota and health #Healthcare cost, quality, practices #Tryptophan and brain disorders
- Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
2023/03/30 by Andrew Blauvelt, Jacob P Thyssen, Jacob P. Thyssen +19 · 26 citations
Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Asthma and respiratory diseases
- Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
2023/10/10 by Marek Jutel, Ioana Agache, Magdalena Zemelka‐Wiacek +37 · 2 citations
- The role of OX40 ligand/OX40 axis signalling in atopic dermatitis
2024/06/03 by Emma Guttman‐Yassky, Emma Guttman-Yassky, Michael Croft +9 · 21 citations
Medicine · #Dermatology and Skin Diseases #Asthma and respiratory diseases #Allergic Rhinitis and Sensitization